Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Tuberous Sclerosis 1Ovarian Neoplasms 1Fallopian Tube Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Paclitaxel 12Carboplatin 12Bevacizumab 11liposomal doxorubicin 8Specimen Handling 8olaparib 7Magnetic Resonance Spectroscopy 7Topotecan 4Gemcitabine 4Biopsy 4pembrolizumab 3mirvetuximab soravtansine 3Taxes 3Doxorubicin 3sarilumab 2niraparib 2cemiplimab 2cediranib 2Immunoglobulin G 2Disulfides 21-dodecylpyridoxal 2trastuzumab deruxtecan 1tocilizumab 1sotorasib 1peposertib 1pelcitoclax 1palbociclib 1nilotinib 1neratinib 1irinotecan sucrosofate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fallopian Tube Neoplasms × Propranolol × 30 days × Clear all
NCT05429970 2026-05-18

A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)

Memorial Sloan Kettering Cancer Center

Phase NA Recruiting
35 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡